Advertisement
The Essential Resource for the Medical Design Engineering Community
Subscribe to MDT Magazine All

How to Make an Artificial Cell

June 13, 2010 8:39 pm | by Massachusetts Institute of Technology | News | Comments

Researchers at the Venter Institute explain their groundbreaking techniques.

Old Livers Made New Again

June 13, 2010 8:39 pm | by Massachusetts Institute of Technology | News | Comments

Unhealthy organs provide a framework for growing replacement ones.

Study reveals causes of survival disparities based on insurance among rectal cancer patients

June 13, 2010 8:37 pm | by EurekAlert | News | Comments

(American Cancer Society) Disparities in cancer stage and treatment are the main reasons why Medicaid-insured and uninsured rectal cancer patients are twice as likely to die within five years as privately insured patients.

TOPICS:
Advertisement

Cost concerns prevent many cancer survivors from getting medical care

June 13, 2010 8:37 pm | by EurekAlert | News | Comments

(American Cancer Society) A new analysis has found that two million cancer survivors did not get needed medical services in the previous year because of concerns about cost.

TOPICS:

Robotic Surgery: Medicine or Marketing?

June 13, 2010 7:41 pm | by Bio-Medicine.Org | News | Comments

An Ethical and Clinical Exploration of the Pros & Cons of Robotic Surgery PHILADELPHIA , June 11 /PRNewswire-USNewswire/ -- Robotic surgery -- is it truly an advance for modern medicine, or just a product of slick consumer advertising campaigns and targeted marketing to physicians?...

TOPICS:

Questcor Receives Notification of PDUFA Date Extension to September 11, 2010

June 13, 2010 7:39 pm | by Bio-Medicine.Org | News | Comments

UNION CITY, Calif. , June 11 /- Questcor Pharmaceuticals, Inc. (Nasdaq: QCOR ) today announced that it has received notification from the U.S. Food & Drug Administration (FDA) that the PDUFA date for Questcor's supplemental new drug application (sNDA) to approve Acthar for the...

TOPICS:

Boehringer Ingelheim Affirms Safety of Telmisartan With an Analysis of 50,000 Patients and Strongly Disagrees With the Publication of Sipahi et al in Lancet Oncology June 2010

June 13, 2010 7:37 pm | by Bio-Medicine.Org | News | Comments

RIDGEFIELD, Conn. , June 13 /- Telmisartan, an angiotensin receptor blocker, is one of the best researched drugs worldwide. It has been studied in clinical trials in more than 50,000 patients. Its positive safety profile has been confirmed also in a market exposure of 34.5 million patient...

TOPICS:

Medical Device and Diagnostic Industry Names Envoy Medical a Company to Watch

June 13, 2010 7:37 pm | by Bio-Medicine.Org | News | Comments

SAINT PAUL, Minn. , June 11 /- Envoy Medical Corporation has been named by Medical Device and Diagnostic Industry as one of the "50 Companies to Watch" in the medical device industry. Medical Device and Diagnostic Industry ("MD+DI"), a monthly magazine dedicated to the medical device and...

TOPICS:
Advertisement

Zargis to Launch FDA-Cleared Lung Sounds Analysis Technology from Stethographics, Inc.

June 13, 2010 7:37 pm | by Bio-Medicine.Org | News | Comments

STAMFORD, Conn. , June 11 /- Zargis Medical Corp., a majority-owned subsidiary of Speedus Corp. (Nasdaq: SPDE ), today announced that it has entered into an agreement with Boston -based Stethographics, Inc. providing an exclusive license to patented, FDA-cleared Stethographics lung sounds...

TOPICS:

Children born after assisted reproduction at greater risk of congenital malformations

June 13, 2010 2:40 pm | by EurekAlert | News | Comments

(European Society of Human Genetics) Couples considering undergoing assisted reproductive technology (ART) treatment should be informed about the increased risk of congenital malformation posed by the use of ART.

TOPICS:

University Hospitals Case Medical Center cardiologists discover cancer risks in blood pressure meds

June 13, 2010 2:37 pm | by EurekAlert | News | Comments

(University Hospitals Case Medical Center) University Hospitals Case Medical Center cardiologists have uncovered new research showing an increased risk of cancer with a group of blood pressure medications known as angiotensin-receptor blockers (ARBs). This class of drugs is used by...

TOPICS:

Small genetic variant can predict response to hepatitis C treatment

June 12, 2010 2:42 pm | by EurekAlert | News | Comments

(European Society of Human Genetics) A small genetic change can predict how people infected with hepatitis C react to treatment, paving the way to personalized therapy for this difficult-to-treat disease.

TOPICS:

Summary Information for: Ethicon? OMNEX? Surgical Sealant (250 & mu;l)

June 12, 2010 3:38 am | by U.S. Food & Drug Administration | News | Comments

Labeling, Approval Order, and Summary of Safety and Effectiveness for Ethicon? OMNEX? Surgical Sealant (250μl) (P060029).

Distant Chemistry Sparks Thoughts Of Life

June 11, 2010 3:39 pm | Podcasts | Comments

Researchers studying the chemical makeup of the atmosphere around Saturn's moon Titan have detected imbalances that, some say, could be signs of life. Jonathan Lunine, a scientist on the Cassini mission to Saturn, says it's too soon to plan a solar-system-wide block party.

Research Tries To Lessen Food Allergies' Bite

June 11, 2010 3:39 pm | Podcasts | Comments

A recent study in the Journal of the American Medical Association found flaws in how food allergies -- abnormal responses to foods triggered by the body's immune system -- are diagnosed. New guidelines on dealing with food allergies are scheduled for publication this fall.

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading